Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 62
Posts 4,879
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Compugen to Present Immune Checkpoint Related Research at Two Scientific Conferences "Business Wire" - 7/24/2014 7:00:00 AM
Compugen Extends Discovery Capabilities to Additional Immunomodulatory Proteins "Business Wire" - 7/14/2014 7:00:00 AM
Compugen Discloses Achievement of Milestone in Cancer Immunotherapy Collaboration with Bayer "Business Wire" - 7/7/2014 7:11:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/7/2014 7:01:29 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/26/2014 4:20:48 PM
Compugen Discloses Experimental Results for Novel Checkpoint Candidate for Cancer Immunotherapy & Discovery of Two New Candid... "Business Wire" - 6/16/2014 7:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 6/11/2014 5:22:07 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/19/2014 7:06:13 AM
Compugen Ltd. Reports First Quarter 2014 Results "Business Wire" - 5/19/2014 7:00:00 AM
U.S. Hot Stocks: Hot Stocks to Watch "Dow Jones News" - 5/12/2014 8:58:08 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/12/2014 7:01:08 AM
Compugen Appoints Mr. Avihai Shen Interim CFO "Business Wire" - 5/12/2014 7:00:00 AM
Compugen First Quarter 2014 Conference Call Scheduled for Monday, May 19, 2014 at 10:00 AM EST "Business Wire" - 5/5/2014 7:00:00 AM
Compugen to Present at Immunology 2014 Conference "Business Wire" - 4/29/2014 7:30:00 AM
Compugen Says Not Being Investigated in Insider-Trading Probe "Dow Jones News" - 4/7/2014 10:28:32 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 4/7/2014 9:11:39 AM
Compugen Statement Regarding Insider Trading Allegations "Business Wire" - 4/7/2014 9:03:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/5/2014 4:11:28 PM
Compugen Ltd. Closes Public Offering of Ordinary Shares "Business Wire" - 3/5/2014 4:05:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/28/2014 2:49:27 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/28/2014 2:47:11 PM
Compugen Ltd. Prices Public Offering of Ordinary Shares "Business Wire" - 2/28/2014 9:15:00 AM
Compugen Ltd. Announces Proposed Public Offering of Ordinary Shares "Business Wire" - 2/27/2014 4:09:00 PM
Compugen to Present Cancer Immunotherapy Programs at Three International Cancer Conferences in March "Business Wire" - 2/20/2014 7:00:00 AM
DAD2   Tuesday, 02/07/12 07:23:17 AM
Re: Fa$tlane post# 111
Post # of 144 
Yep its posted:

Zero revenues in the 4th quarter and the net loss for the 4th quarter was $4.4 million.

Might pull back slightly imo.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist